1. Home
  2. DRTS vs AACB Comparison

DRTS vs AACB Comparison

Compare DRTS & AACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRTS
  • AACB
  • Stock Information
  • Founded
  • DRTS 2015
  • AACB 2024
  • Country
  • DRTS Israel
  • AACB United States
  • Employees
  • DRTS N/A
  • AACB N/A
  • Industry
  • DRTS Medical/Dental Instruments
  • AACB
  • Sector
  • DRTS Health Care
  • AACB
  • Exchange
  • DRTS Nasdaq
  • AACB Nasdaq
  • Market Cap
  • DRTS 274.0M
  • AACB 299.3M
  • IPO Year
  • DRTS N/A
  • AACB 2025
  • Fundamental
  • Price
  • DRTS $3.06
  • AACB $10.14
  • Analyst Decision
  • DRTS Strong Buy
  • AACB
  • Analyst Count
  • DRTS 2
  • AACB 0
  • Target Price
  • DRTS $8.00
  • AACB N/A
  • AVG Volume (30 Days)
  • DRTS 41.1K
  • AACB 665.0
  • Earning Date
  • DRTS 08-13-2025
  • AACB 01-01-0001
  • Dividend Yield
  • DRTS N/A
  • AACB N/A
  • EPS Growth
  • DRTS N/A
  • AACB N/A
  • EPS
  • DRTS N/A
  • AACB N/A
  • Revenue
  • DRTS N/A
  • AACB N/A
  • Revenue This Year
  • DRTS N/A
  • AACB N/A
  • Revenue Next Year
  • DRTS N/A
  • AACB N/A
  • P/E Ratio
  • DRTS N/A
  • AACB N/A
  • Revenue Growth
  • DRTS N/A
  • AACB N/A
  • 52 Week Low
  • DRTS $1.93
  • AACB $10.00
  • 52 Week High
  • DRTS $4.39
  • AACB $11.35
  • Technical
  • Relative Strength Index (RSI)
  • DRTS 49.92
  • AACB N/A
  • Support Level
  • DRTS $2.95
  • AACB N/A
  • Resistance Level
  • DRTS $3.15
  • AACB N/A
  • Average True Range (ATR)
  • DRTS 0.14
  • AACB 0.00
  • MACD
  • DRTS -0.02
  • AACB 0.00
  • Stochastic Oscillator
  • DRTS 27.50
  • AACB 0.00

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.

About AACB Artius II Acquisition Inc. Class A Ordinary Shares

Artius II Acquisition Inc is a blank check company.

Share on Social Networks: